A flashpoint in the recent election surrounds children who want to live life as the opposite sex, a mental disorder classified as gender dysphoria. Controversy over treatments drove votes toward Donald Trump and changes are certain to come under his […]
Heated battles are shaping up over the government’s increasingly aggressive efforts to crack down on natural food producers. Sunday on Full Measure, we look at the raw milk controversy. Some health advocates argue the government is reducing consumer choice while
The govt. food police; Kentucky coal; Banning puberty blockers Read More »
Subcommittee on Health Care and Financial Services Chairwoman Lisa McClain (R-Mich.) is conducting oversight of the National Institutes of Health (NIH) after the results of a $9.7 million taxpayer-funded research project studying the effects of puberty blockers for transgender youth
(READ) McClain probes $9.7M puberty blocker study withheld from public Read More »
The following is from BBC News. Puberty blockers will only be prescribed to children attending gender identity services as part of clinical research, NHS [National Health Service] England has announced. The move comes after an interim report into children’s gender services said
UK restricts controversial use of puberty blockers in gender-confused children Read More »
The following is an excerpt from Medpage Today. Florida’s medical boards approved a rule on Friday banning gender-affirming medications and surgery for youth with gender dysphoria who aren’t already being treated. The Florida Board of Medicine voted to adopt a proposed
Florida medical boards ban gender-affirming care for kids Read More »
Rep. Nancy Mace (R-South Carolina) wants to know why taxpayer dollars are being spent to promote radical gender ideology and the medical “transition” of children from biological male to copying the appearance of a female, or vice versa, using pharmaceutical
(READ) Republican questions HHS on taxpayer-funded child gender transition research Read More »
Sen. Marsha Blackburn (R-Tenn.) is asking the FDA to provide information about the controversial use of certain puberty blockers in children who suffer from gender dysphoria and wish to resemble the opposite sex. Blackburn says she was motivated to write
(READ) Senator calls for FDA investigation into use of puberty blockers Read More »
The following is an excerpt from The Daily Wire. Puberty blockers, known as gonadotropin-releasing hormone (GnRH) substances, received a warning from U.S. Food and Drug Administration (FDA) officials earlier this month, saying the drug could cause brain swelling, loss of vision,
